Round Rock Advisors LLC Takes Position in DENTSPLY SIRONA Inc. $XRAY

Round Rock Advisors LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 53,922 shares of the medical instruments supplier’s stock, valued at approximately $572,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth $283,405,000. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 3.2% during the 4th quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock worth $167,342,000 after acquiring an additional 458,744 shares in the last quarter. AQR Capital Management LLC increased its position in DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the period. Lazard Asset Management LLC raised its holdings in shares of DENTSPLY SIRONA by 0.9% in the 3rd quarter. Lazard Asset Management LLC now owns 10,200,525 shares of the medical instruments supplier’s stock valued at $129,445,000 after purchasing an additional 92,868 shares in the last quarter. Finally, Southpoint Capital Advisors LP purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $116,000,000. 95.70% of the stock is owned by institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Brian T. Gladden acquired 9,985 shares of DENTSPLY SIRONA stock in a transaction on Monday, June 15th. The stock was acquired at an average price of $10.02 per share, for a total transaction of $100,049.70. Following the purchase, the director owned 61,849 shares of the company’s stock, valued at approximately $619,726.98. This represents a 19.25% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Michael J. Barber bought 15,175 shares of the stock in a transaction dated Thursday, June 11th. The stock was bought at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the purchase, the director directly owned 55,943 shares of the company’s stock, valued at approximately $552,716.84. The trade was a 37.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 35,160 shares of company stock worth $351,179. Insiders own 0.46% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on XRAY. Mizuho reduced their price objective on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. UBS Group cut their price target on DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Piper Sandler upped their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Barclays lifted their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Finally, BMO Capital Markets restated a “market perform” rating and issued a $13.00 price target on shares of DENTSPLY SIRONA in a report on Friday, August 7th. Three investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $13.54.

DENTSPLY SIRONA Stock Performance

XRAY opened at $11.29 on Thursday. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. DENTSPLY SIRONA Inc. has a 12-month low of $9.40 and a 12-month high of $14.86. The firm has a 50 day moving average of $12.14 and a two-hundred day moving average of $11.68. The firm has a market capitalization of $2.25 billion, a PE ratio of -4.11, a P/E/G ratio of 1.37 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. During the same quarter in the prior year, the business earned $0.52 earnings per share. The business’s quarterly revenue was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current year.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.